OLANAMO-150 contains Olaparib (150 mg), a targeted PARP inhibitor used to treat advanced ovarian, breast, pancreatic, and prostate cancers with specific genetic mutations (like BR…
OLANAMO-150 contains Olaparib (150 mg), a targeted PARP inhibitor used to treat advanced ovarian, breast, pancreatic, and prostate cancers with specific genetic mutations (like BRCA). The standard adult dosage is 300 mg (two 150 mg tablets) taken orally twice daily.
liketo.usa,uk,china,southkorea,russia,japan,singapore
Strength 150 mg
Dose/Strength 150 mg
Brand Olanamo
Tablets per Pack 56 Tablets
Usage Cancer Care
Pack Type Bottle
Packaging Type Bottle
Packaging Size 1*120 Tablets
Country of Origin Made in India
Form Tablet
Minimum order quantity: 50 Box
Composition details not available.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
